Tamaki Kato

Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.

Yasuhiko Komatsu, Kin‐ya Tomizaki, Makiko Tsukamoto et al. · PubMed · 2001 · 146 citations

Bioorganic Chemistry, Antitumor Activity, Chemoprevention Strategy +18

Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome–like immunodeficiency

Yuki Tsujita, Kanako Mitsui‐Sekinaka, Kohsuke Imai et al. · Journal of Allergy and Clinical Immunology · 2016 · 96 citations · Full text

Cyclic Tetrapeptides Bearing a Sulfhydryl Group Potently Inhibit Histone Deacetylases

Norikazu Nishino, Binoy Jose, Shinji Okamura et al. · Organic Letters · 2003 · 66 citations

Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1

Tsubasa Okano, Kohsuke Imai, Yuki Tsujita et al. · Journal of Allergy and Clinical Immunology · 2018 · 65 citations · Full text

Primary Immunodeficiency, Type 1, Transplantation +7

Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones

Binoy Jose, Yusuke Oniki, Tamaki Kato et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 62 citations · Full text

Medicinal Chemistry, Pentafluoroethyl Ketones, Biochemistry +10